PRKAR1A and hyperinsulinism: Examination of the Sur1-/- hyperinsulinism mouse model in the context of Prkar1a reduction, identified a distinct increase in not only fasting plasma glucose levels, but also a significant decrease in fasting insulin/glucose levels as well (Fig 4).